EP2854826 - LACTOBACILLUS REUTERI ATCC PTA 6475 FOR USE IN PREVENTION OR TREATMENT OF BONE LOSS IN MAMMALS [Right-click to bookmark this link] | |||
Former [2015/15] | SELECTION AND USE OF LACTIC ACID BACTERIA PREVENTING BONE LOSS IN MAMMALS | ||
[2018/26] | Status | No opposition filed within time limit Status updated on 20.09.2019 Database last updated on 18.11.2024 | |
Former | The patent has been granted Status updated on 12.10.2018 | ||
Former | Grant of patent is intended Status updated on 17.06.2018 | ||
Former | Examination is in progress Status updated on 09.02.2018 | Most recent event Tooltip | 01.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 03.08.2022 [2022/31] | Applicant(s) | For all designated states BIOGAIA AB Box 3242 103 64 Stockholm / SE | For all designated states Michigan State University 325 E. Grand River Suite 350 East Lansing, Michigan 48823 / US | [2015/15] | Inventor(s) | 01 /
CONNOLLY, Eamonn Motionsvägen 3 S-181 29 Lidingö / SE | 02 /
BRITTON, Robert Allen 2807 Ridge Falls Drive Manvel, TX 77578 / US | 03 /
MCCABE, Laura Rae 1330 Orlando Drive Haslett, Michigan 48840 / US | [2015/32] |
Former [2015/15] | 01 /
CONNOLLY, Eamonn Motionsvägen 3 S-181 29 Lidingö / SE | ||
02 /
BRITTON, Robert Allen 1209 Blanchette Drive East Lansing, Michigan 48823 / US | |||
03 /
MCCABE, Laura Rae 1330 Orlando Drive Haslett, Michigan 48840 / US | Representative(s) | Brann AB P.O. Box 3690 Sveavägen 63 103 59 Stockholm / SE | [N/P] |
Former [2018/46] | Brann AB P.O. Box 3690 Drottninggatan 27 103 59 Stockholm / SE | ||
Former [2015/15] | Brann AB P.O. Box 12246 102 26 Stockholm / SE | Application number, filing date | 13800449.4 | 04.06.2013 | [2018/46] | WO2013SE50646 | Priority number, date | US201261689338P | 04.06.2012 Original published format: US 201261689338 P | [2015/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013184064 | Date: | 12.12.2013 | Language: | EN | [2013/50] | Type: | A1 Application with search report | No.: | EP2854826 | Date: | 08.04.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.12.2013 takes the place of the publication of the European patent application. | [2015/15] | Type: | B1 Patent specification | No.: | EP2854826 | Date: | 14.11.2018 | Language: | EN | [2018/46] | Type: | B9 Corrected patent specification | No.: | EP2854826 | Date: | 08.05.2019 | [2019/19] | Search report(s) | International search report - published on: | SE | 12.12.2013 | (Supplementary) European search report - dispatched on: | EP | 07.06.2016 | Classification | IPC: | A61K35/747, A61P19/08, A23L33/135 | [2018/26] | CPC: |
A61K35/747 (EP,KR,US);
A23L33/135 (EP,KR,US);
A61K31/59 (EP,US);
A61P19/00 (EP);
A61P19/08 (EP);
A61P19/10 (EP);
C12N1/20 (US);
C12Q1/689 (US);
A23V2002/00 (EP,US);
A61K2035/11 (US);
C12Q2600/156 (US);
C12Q2600/16 (US);
C12R2001/225 (KR)
(-)
| C-Set: |
A23V2002/00, A23V2200/306, A23V2400/11, A23V2400/173 (EP,US)
|
Former IPC [2016/27] | A61K35/74, A61P19/08, C12Q1/68, A23L33/135 | ||
Former IPC [2015/15] | A61K35/74, A23L1/30, A61P19/08 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/15] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | LACTOBACILLUS REUTERI ATCC PTA 6475 ZUR VERWENDUNG BEI VORBEUGUNG ODER BEHANDLUNG VON KNOCHENABBAU BEI SÄUGETIEREN | [2018/26] | English: | LACTOBACILLUS REUTERI ATCC PTA 6475 FOR USE IN PREVENTION OR TREATMENT OF BONE LOSS IN MAMMALS | [2018/26] | French: | LACTOBACILLUS REUTERI ATCC PTA 6475 ET SON UTILISATION DANS LA PREVENTION OU LE TRAITEMENT DE LA PERTE OSSEUSE CHEZ DES MAMMIFÈRES | [2018/26] |
Former [2015/15] | AUSWAHL UND VERWENDUNG VON MILCHSÄUREBAKTERIEN ZUR VORBEUGUNG VON KNOCHENABBAU BEI SÄUGETIEREN | ||
Former [2015/15] | SELECTION AND USE OF LACTIC ACID BACTERIA PREVENTING BONE LOSS IN MAMMALS | ||
Former [2015/15] | SÉLECTION ET UTILISATION DE BACTÉRIES LACTIQUES PRÉVENANT LA PERTE OSSEUSE CHEZ DES MAMMIFÈRES | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 19.12.2014 | National basic fee paid | 19.12.2014 | Search fee paid | 19.12.2014 | Designation fee(s) paid | 19.12.2014 | Examination fee paid | Examination procedure | 19.12.2014 | Examination requested [2015/15] | 22.12.2016 | Amendment by applicant (claims and/or description) | 08.02.2018 | Despatch of a communication from the examining division (Time limit: M04) | 20.03.2018 | Reply to a communication from the examining division | 18.06.2018 | Communication of intention to grant the patent | 02.10.2018 | Fee for grant paid | 02.10.2018 | Fee for publishing/printing paid | 02.10.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | EP18202594.0 / EP3456334 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 08.02.2018 | Opposition(s) | 15.08.2019 | No opposition filed within time limit [2019/43] | Fees paid | Renewal fee | 12.06.2015 | Renewal fee patent year 03 | 20.06.2016 | Renewal fee patent year 04 | 29.06.2017 | Renewal fee patent year 05 | 20.06.2018 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 14.11.2018 | AT | 14.11.2018 | CY | 14.11.2018 | EE | 14.11.2018 | MC | 14.11.2018 | MK | 14.11.2018 | MT | 14.11.2018 | RO | 14.11.2018 | RS | 14.11.2018 | SM | 14.11.2018 | BG | 14.02.2019 | GR | 15.02.2019 | IS | 14.03.2019 | PT | 14.03.2019 | LU | 04.06.2019 | [2022/31] |
Former [2021/34] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
CY | 14.11.2018 | ||
EE | 14.11.2018 | ||
MC | 14.11.2018 | ||
MT | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SM | 14.11.2018 | ||
BG | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
LU | 04.06.2019 | ||
Former [2021/26] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
CY | 14.11.2018 | ||
EE | 14.11.2018 | ||
MC | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SM | 14.11.2018 | ||
BG | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
LU | 04.06.2019 | ||
Former [2020/27] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
EE | 14.11.2018 | ||
MC | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SM | 14.11.2018 | ||
BG | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
LU | 04.06.2019 | ||
Former [2020/08] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
EE | 14.11.2018 | ||
MC | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SM | 14.11.2018 | ||
BG | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
Former [2019/37] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
EE | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SM | 14.11.2018 | ||
BG | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
Former [2019/26] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
RS | 14.11.2018 | ||
BG | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
Former [2019/25] | AT | 14.11.2018 | |
RS | 14.11.2018 | ||
BG | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
Former [2019/24] | AT | 14.11.2018 | |
BG | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
Former [2019/23] | AT | 14.11.2018 | |
BG | 14.02.2019 | ||
IS | 14.03.2019 | ||
Former [2019/22] | BG | 14.02.2019 | |
IS | 14.03.2019 | ||
Former [2019/21] | IS | 14.03.2019 | Documents cited: | Search | [Y]US2008254011 (ROTHSCHILD PETER [SE], et al) [Y] 1-14 * the whole document *; | [Y] - BRENDAN E BOYCE ET AL, "TNF.ALPHA. and pathologic bone resorption", KEIO JOURNAL OF MEDICINE., JP, (20050101), vol. 54, no. 3, doi:10.2302/kjm.54.127, ISSN 0022-9717, pages 127 - 131, XP055270832 [Y] 1-14 * the whole document * DOI: http://dx.doi.org/10.2302/kjm.54.127 | [Y] - SCHOLZ-AHRENS K E ET AL, "Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure", THE JOURNAL OF NUTRITION, AMERICAN SOCIETY FOR NUTRITION, US, (20070301), vol. 137, no. 3, Suppl. S, ISSN 0022-3166, pages 838S - 846S, XP002737535 [Y] 1-14 * the whole document * | [Y] - CHING-YI LAI ET AL, "Preventing Bone Loss and Weight Gain with Combinations of Vitamin D and Phytochemicals", JOURNAL OF MEDICINAL FOOD, (20111101), vol. 14, no. 11, doi:10.1089/jmf.2010.0232, ISSN 1096-620X, pages 1352 - 1362, XP055190442 [Y] 13 * the whole document * DOI: http://dx.doi.org/10.1089/jmf.2010.0232 | [A] - IYER CHANDRA ET AL, "Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling.", CELLULAR MICROBIOLOGY JUL 2008, (200807), vol. 10, no. 7, ISSN 1462-5822, pages 1442 - 1452, XP002757502 [A] 1-14 * the whole document * DOI: http://dx.doi.org/10.1111/j.1462-5822.2008.01137.x | [T] - BRITTON ROBERT A ET AL, "Probiotic L. reuteri Treatment Prevents Bone Loss in a Menopausal Ovariectomized Mouse Model", JOURNAL OF CELLULAR PHYSIOLOGY, (201411), vol. 229, no. 11, pages 1822 - 1830, XP002757503 DOI: http://dx.doi.org/10.1002/jcp.24636 | International search | [X]WO03105893 (ALIMENTARY HEALTH LTD [IE], et al); | [X]WO2006110088 (BIOGAIA AB [SE]); | [A]WO2008028300 (UNIV MCGILL [CA], et al); | [X]EP1918373 (SCHOOL CORP AZABU VETERINARY M [JP]); | [X] - WALTER J. ET AL., "Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm", PNAS, (2011), vol. 108, pages 4645 - 4652, XP055179162 DOI: http://dx.doi.org/10.1073/pnas.1000099107 | [X] - REGISTRY, (20130910), Database accession no. 1268657-11-9, URL: STN, XP055185531 | [A] - KIM J. G. ET AL., "Effects of a Lactobacillus casei 393 fermented milk product on bone metabolism in ovariectomised rats", INTERNATIONAL DAIRY JOURNAL, (2009), vol. 19, pages 690 - 695, XP026562825 DOI: http://dx.doi.org/10.1016/j.idairyj.2009.06.009 | [XP] - MCCABE L. R. ET AL., "Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice", JOURNAL OF CELLULAR PHYSIOLOGY, (20130418), vol. 228, pages 1793 - 1798, XP055179166 DOI: http://dx.doi.org/10.1002/jcp.24340 | [L] - MCCABE L. R., "Probiotics and bone health - Role of gender and intestinal health", NIH OFFICE OF DIETARY SUPPLEMENTS GRANT ABSTRACT, GRANT NUMBER: 1 R21 AT005472-01 A1, XP055179188 | by applicant | - NARVA et al., Effects of bioactive peptide, valyl-prolyl-proline (VPP), and lactobacillus helveticus fermented milk containing VPP on bone loss in ovariectomized rats | - NARVA et al., The effect of Lactobacillus helveticus fermented milk on acute changes in calcium metabolism in postmenopausal women | - YEO et al., Angiotensin I-converting enzyme inhibitory activity and bioconversion of isoflavones by probiotics in soymilk supplemented with prebiotics | - KIM et al., Effects of a Lactobacillus casei 393 fermented milk product on bone metabolism in ovariectomised rats | - WALTER et al., "Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm", PNAS, vol. 108, doi:doi:10.1073/pnas.1000099107, pages 4645 - 4652, XP055179162 DOI: http://dx.doi.org/10.1073/pnas.1000099107 | - "GenBank", Database accession no. AP007281 |